Business
Merck snags Chinese cancer drug for up to US$3.3 billion
MERCK & Co licenced an experimental cancer antibody from a closely held Chinese company in a deal worth US$588 million upfront, plus as…
Tag
MERCK & Co licenced an experimental cancer antibody from a closely held Chinese company in a deal worth US$588 million upfront, plus as…
HYUNDAI Motor India shares slipped as much as 2.6 per cent early in their Mumbai debut, a lacklustre start to trading in what has been one…
CROP trader Olam Group will pay a US$3.3 million fine for delayed reporting of cotton sales to the US Department of Agriculture (USDA) and…